• Pharma News - All the latest pharmaceutical news from across the web

Search Results for text, 'Novartis'

« Page 1 of 369 pages, displaying 1-10 of 3681 results »

Cutaneous Mastocytosis Market Analysis and Global Research Report 2019 – Novartis, BioCentury, Rarediseases - The Ukiah Post

Cutaneous Mastocytosis Market research report gives informative data of the current market Trends, scenario with latest markets updated news and opportunities which are helpful for business development. This report provides circumstances of the latest technology which is helpful in Medical industry for analysis of number of disorders Treatment Methodology, diagnostics and therapies. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. Also, provides details of leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Novartis' Jakavi Meets Primary Goal in Phase III for GVHD

Novartis AG (NVS - Free Report) announced that the phase III REACH2 study, which evaluated Jakavi (ruxolitinib) for treating patients with steroid-refractory acute graft-versus-host disease (GVHD), has met the primary endpoint.

You Need to Know Signal? Novartis AG (NVS)

Novartis AG (NVS) Stock’s Price Fluctuations & Volatility:

Novartis unit spikes Pear Therapeutics deal

Novartis (NYSE:NVS) unit Sandoz said this week that Pear Therapeutics will take sole responsibility for the commercialization of their prescription digital therapeutics program for treating substance and opioid use disorders.

Competitors Analysis in Neurotherapeutic Drugs Market 2020 || Abbott, BD, Novartis AG

Global Cytokines Market Insights 2019 – AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis, Roche, Pfizer, Sanofi

Lapatinib Market Trends 2019 | Growth by Top Companies: Novartis – Pledge Times

Global Lapatinib market Research Report includes data of the Top key industry players and their scope and share. The report offers types, investments, growth ratio, applications, manufacturers, opportunities, challenges. Future developments and latest contracts awarded in the market across different regions are demonstrated in the report.

Neuroendocrine Tumor Treatment Market Forecast 2019 By Companies Exelixis, Ispen, Novartis AG, Tarveda Therapeutics - Galus Australis

Based on the study, the Neuroendocrine Tumor Treatment Market report offers a comprehensive outlook of current marketing trends as well as brand new product development in the global Neuroendocrine Tumor Treatment market. Along with detailed description regarding the worldwide and regional analysis, this Neuroendocrine Tumor Treatment market report also elaborates key player’s profiles and meanwhile, it works as the ultimate guide for exhibiting plenty of opportunities available in the Neuroendocrine Tumor Treatment market internationally. It is also known as a significant tool to check out the desire feasibility of a new project and geological expansion of the leading firms.

Global Anti-infective Ophthalmic Market 2019 Rising Trends - Novartis, Allergan, Valeant Pharmaceuticals - Top News Herald

Fior Market’s latest presentation named 2019-2024 Global Anti-infective Ophthalmic Consumption Market Report centers around the progress of this market, focusing on its development status and trends. The report concentrates on the business strategies of the key vendors, market fundamental dynamics including compound annual growth rate, drivers and trends dynamics during the forecast period (2019-2024).  An in-depth analysis of Anti-infective Ophthalmic enfolds market drivers, challenges, standardization, opportunities, limitations, ecosystem player profiles, and strategies.

Ocyodinic Market Comprehensive Insights 2019 to 2025 | Pfizer, Novartis, Baxter Healthcare, Biofutura, Ferring - The Ukiah Post

« Page 1 of 369 pages, displaying 1-10 of 3681 results »